Current evidence suggests that overexpression of MyoZ2 can inhibit calcineurin-dependent signaling and result in overload-induced cardiac hypertrophy as well as arterial hypertension [45, 46]. The gene discussed is MYOZ2; the disease is cardiac hypertrophy.